Investors of Indian pharmaceutical companies are worried about the prospect of further escalation amid U.S. trade tensions.

U.S. customs officials said on Thursday they were investigating whether Indian solar company Waaree Energies sidestepped U.S.

Bank is increasing credit support to exporters and helping them diversify into newer markets, particularly Africa, following ...

US tariffs on patented drugs won’t hit Indian pharma immediately, says Bhaskar Chakravorti, but future risk to generics ...

From the start of October, imported branded drugs will face a steep 100 per cent duty, while heavy-duty trucks will carry a ...

The latest wave of tariffs will take effect on October 1. Earlier, the Ministry of External Affairs (MEA) said it is ...

Trump’s tariffs have given India’s economy a sharp shock, forcing it to confront its vulnerabilities and accelerate ...

In 2023, PM Modi called Donald Trump his special friend.  Two years on, 'that friendship' is being tested and it may be costing Indians jobs, visas and the ...

India rejected as "incorrect and baseless" remarks by NATO's chief that suggested Indian Prime Minister Narendra Modi was ...

Taiwan is seeking to double its exports of chips and electronics to India over the next five to seven years as smartphone ...

US tariffs on Indian goods linked to Russian oil purchases; negotiations ongoing for resolution, potential increase in US oil ...

New Delhi has doubled down on domestic reforms and international engagement in the face of Washington’s tariffs, seeking ...